Each point was worked out with the data available that day. Scale 0-10: 5 is the index average and 10 is the cap (+3 standard deviations), not perfection. The vertical axis zooms to fit this company, so two charts are not comparable by eye.
Market and Valuation
Price & Market
Prev Close Price:$307.00
Open:$303.00
Day's Low:$299.07
Day's High:$306.55
Bid / Ask:-
Market Cap:49.09B
Enterprise Value:42.61B
52-Week Range
52-Week Low:$148.05
52-Week High:$325.99
Current position in 52-week range
52w Low-52w High
50-Day Avg:$285.04
200-Day Avg:$209.67
Volume
Volume Today:1,419,516
Avg Volume (3m):1,674,570
Avg Volume (10d):1,448,480
52-Week Change:+4.60%
vs S&P 500, 52 weeks:-
Beta:0.88
Valuation Multiples
P/E (trailing):49.63
Diluted EPS for the last 12 months: the four quarters ended Jul 31, 2026, from the accounts filed with the SEC on Aug 27, 2026. The P/E is the price divided by that EPS.
P/E (forward):29.56
PEG Ratio:1.18
Price / Book:6.60
Price / Sales (TTM):14.20
EV / Revenue:12.32
EV / EBITDA:39.63
Dividends
Current yield:-
Annual Dividend Rate:-
Dividend Trailing:$0.00
Yield Trailing:0.00%
5-Year Avg Yield:-
Payout Ratio:0.00%
Last Ex-Dividend Date:-
Valuation Context
P/E vs sector (indicative)
Most Recent Quarter:-
Fiscal Year (Next):-
Loading historical OHLCV database...
Date
Open
High
Low
Close
Volume
Financial Statements TTM (Trailing 12 Months)
Income Statement
Total Revenue (TTM):3.46B
Gross Profit:2.59B
EBITDA:1.08B
Net Income (TTM):1.01B
Rev Growth (YoY):+17.60%
Earnings Growth (YoY):+39.50%
Quarterly earnings growth (YoY):+36.50%
Margins
Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-
Per Share
EPS Trailing (TTM):$6.11
Diluted EPS for the last 12 months: the four quarters ended Jul 31, 2026, from the accounts filed with the SEC on Aug 27, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$10.26
Revenue Per Share:$21.15
Cash Per Share:-
Book Value:$45.92
Last Dividend:-
Ex-Dividend Date:-
Last Split:-
Balance Sheet & Liquidity
Total cash:7.24B
Total Debt:151.70M
Net Debt (Debt - Cash):−7.09B (net cash)
Debt / Equity:2.04%
Current Ratio:5.46
Quick Ratio:5.36
Cash Flows
Operating Cash Flow:1.67B
Free Cash Flow (FCF):1.26B
FCF Yield (FCF / Market Cap):-
Enterprise Value:42.61B
EV / Revenue:12.32
EV / EBITDA:39.63
Profitability
ROE (Return on Equity):14.43%
ROA (Return on Assets):7.58%
P/E (trailing):49.63
P/E (forward):29.56
Price / Book:6.60
PEG Ratio:1.18
52-Week Change:+4.60%
S&P 500 change, 52 weeks:+11.37%
Historical Evolution (Last 4 Years)
Income Statement
Balance Sheet
Cash Flow
EPS and Earnings Per Share
Key EPS Metrics
EPS Trailing (TTM):$6.11
Diluted EPS for the last 12 months: the four quarters ended Jul 31, 2026, from the accounts filed with the SEC on Aug 27, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$10.26
P/E (forward):29.56
PEG Ratio:1.18
Growth and Margins
Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-
Per Share
Revenue Per Share:$21.15
Cash Per Share:-
Book Value:$45.92
Cash Flows (TTM)
Free Cash Flow:1.26B
Operating Cash Flow:1.67B
EBITDA:1.08B
Total Revenue (TTM):3.46B
Net Income (TTM):1.01B
Fiscal Year (Last):-
EPS Surprise History - Last 4 Quarters
Actual vs. Analyst Estimates · Green = beat expectations · Red = missed
Quarter
Period
Actual EPS
Estimated EPS
Difference
Surprise %
Currency
Ownership Structure
Ownership Distribution
% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float
Shares & Short Interest
Shares Outstanding:161,908,850
Float (free shares):148,274,506
Short interest (shares):4,203,799
Short % of float:-
Short Ratio (days to cover):2.59
Short interest, prior month:-
Short Interest Date:-
Governance Score (1=Best, 10=Worst)
Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-
Top Institutional Holders
Position Change: ▲ Increased · ▼ Reduced · = Unchanged
Organization
Report Date
% Shares
No. Shares
Value (USD)
Change %
Top Mutual Funds
Position Change: ▲ Increased ▼ Decreased = Unchanged
Fund
Report Date
% Shares
No. Shares
Value (USD)
Change %
Recent Insider Trades
Executive / Insider
Title
Date
Action
Shares
Options Chain
CALLS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
PUTS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
Sentiment Metrics
Put/Call Ratio (Volume):-
Put/Call Ratio (O.I.):-
Max Pain (estimated):-
Total O.I. Calls:-
Total O.I. Puts:-
Expected move
Average IV (Calls ATM):-
Average IV (Puts ATM):-
Days to Expiration:-
Expected move (±):-
Veeva Systems Inc. (VEEV) SEC filings: 10-K, 10-Q and 8-K
Direct links to financial reports filed with the SEC.
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.
No card. No spam.
Veeva Systems Inc. (VEEV): Quantitative Analysis
Veeva Systems Inc. (VEEV) — Healthcare — Health Information Services. VEEV is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.
So far in 2026, VEEV has returned +35.8% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.
VEEV ranks 274 of 461 on today's multifactor score, and 38 of the 55 Healthcare companies that score. Its strongest factor is quality (Z 0.45, ranked 83 of 468); its weakest is value (Z -0.66, ranked 439 of 489). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.
Factor scores
The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.
Frequently asked questions about Veeva Systems (VEEV)
When does Veeva Systems report earnings?
According to Nasdaq's public calendar (checked on Nov 4, 2026), Veeva Systems will report its next earnings on Nov 19, 2026, with no time announced. The date is announced by the company itself and can change. Of its last 12 earnings announcements: 12 after the close (SEC filings through Aug 26, 2026). VEEV earnings dates and times, quarter by quarter →
What is Veeva Systems's P/E ratio?
Veeva Systems's P/E (price over earnings per share for the last twelve months) is 49.6 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Jul 31, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Veeva Systems is above its sector median. Healthcare stocks, company by company →
Where does Veeva Systems rank on Quant500?
In the Nov 3, 2026 multi-factor ranking, Veeva Systems ranks 274 of 461, and 38 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking →How it is calculated →
Have Veeva Systems insiders bought or sold shares?
SEC Form 4 shows no open-market purchase of Veeva Systems shares from August 2025 through Nov 3, 2026. The latest sale was on Oct 14, 2026, by an officer, for $1.6M. In total, from August 2025 through Nov 3, 2026: 0 purchases and 15 sales by directors, officers and large shareholders. All VEEV insider trades →
What sector is Veeva Systems in, and which index?
Veeva Systems is classified in the Healthcare sector (industry: Health Information Services), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →
What is behind these numbers
The concepts on this page, explained from scratch in the Academy. Free, no account.
Quality and low volatilityWhere the quality score comes from, and why it is the factor with the most competing definitions, all of them called the same thing.
We save the portfolios you design, your own portfolio and your Academy progress, synced across devices.
Free, no card. Two automatic emails and no more: the one that confirms your address and the welcome one. After that, nothing you do not switch on yourself in your profile — such as the alert for insider buys, the same day they are reported to the SEC.